LJPC-6417

N/A

Report date: 2025/03/14 15:13:26
NME

Base Information

Drug NameLJPC-6417
Drug Alias NameLJPC-6417
ClassificationOther
Mechanisms of ActionBone morphogenetic protein receptor type I antagonists
TargetsBone morphogenetic protein receptor type I
Therapy Area/IndicationsMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLa Jolla Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLa Jolla Pharmaceutical Company
Active IndicationsN/A
Inactive IndicationsMyositis Ossificans

Other Information

ATC CodeN/A
Related LinksN/A